ÂÜÀòÂÒÂ×

Scott Hayton is a highly experienced professional in the biotech and pharmaceutical sectors, currently serving as Senior Operating Principal at Flagship Pioneering and Acting Chief Operating Officer at Quotient Therapeutics. With a strong background in strategy and operations, Scott has held key leadership roles at McKinsey & Company, contributing as an Associate Partner and Engagement Manager within the Pharmaceutical and Medical Products Practice. Additionally, Scott has experience in special projects at Gates Ventures and a robust academic background, earning a PhD in Neuroscience from Queen's University, where significant research on impulsivity resulted in multiple publications. Scott's expertise is further complemented by teaching experience at the undergraduate level during tenure as an Adjunct Lecturer.